0001192482-14-000229.txt : 20141112 0001192482-14-000229.hdr.sgml : 20141111 20141112123931 ACCESSION NUMBER: 0001192482-14-000229 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141110 FILED AS OF DATE: 20141112 DATE AS OF CHANGE: 20141112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TETRALOGIC PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001361248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 343 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-889-9900 MAIL ADDRESS: STREET 1: 343 PHOENIXVILLE PIKE CITY: MALVERN STATE: PA ZIP: 19355 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schmitt Paul J CENTRAL INDEX KEY: 0001390406 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36208 FILM NUMBER: 141212750 MAIL ADDRESS: STREET 1: PA EARLY STAGE PARTNERS STREET 2: 1200 LIBERTY RIDGE DRIVE, SUITE 310 CITY: WAYNE STATE: PA ZIP: 19087 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-11-10 0001361248 TETRALOGIC PHARMACEUTICALS CORP TLOG 0001390406 Schmitt Paul J C/O NOVITAS CAPITAL III, L.P. 116 RESEARCH DRIVE BETHLEHEM PA 18015 1 0 0 0 Common Stock 2014-11-10 4 P 0 10000 4.063 A 10000 D Common Stock 1512962 I See footnote Common Stock 2014-11-10 4 P 0 10000 4.1352 A 10000 I See footnote The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.01 to $4.0968, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The securities are held of record by Novitas Capital III, LP. ("Novitas III"), Novitas Capital III GP, LP ("Novitas GP") and Novitas Capital III GP Manager, LLC ("Novitas Manager"). Novitas GP is the general partner of Novitas III and Novitas Manager is the general partner of Novitas GP. The reporting person, a partner in HVPIII and HVAIII, has voting and investment power over the shares beneficially owned by HVPIII and HVAIII, and disclaims beneficial ownership of the shares beneficially owned by Novitas III, Novitas GP and Novitas Manager, except to the extent of his pecuniary interest therein. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.0488 to $4.2673, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The securities are held of record by the reporting person's spouse, Sharon Z. Schmitt. The reporting person does not have voting and investment power over the shares beneficially owend by Sharon Z. Schmitt, and disclaims beneficial ownership of the shares beneficially owned by Sharon Z. Schmitt. /s/ Richard L. Sherman, Attorney-In-Fact for Paul J. Schmitt 2014-11-12